Cover
Cover | Jun. 06, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jun. 06, 2024 |
Entity File Number | 1-38519 |
Entity Registrant Name | Serina Therapeutics, Inc. |
Entity Central Index Key | 0001708599 |
Entity Tax Identification Number | 82-1436829 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 601 Genome Way |
Entity Address, Address Line Two | Suite 2001 |
Entity Address, City or Town | Huntsville |
Entity Address, State or Province | AL |
Entity Address, Postal Zip Code | 35806 |
City Area Code | (256) |
Local Phone Number | 327-9630 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | SER |
Security Exchange Name | NYSEAMER |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |